Long-term effectiveness of dupilumab in patients with atopic dermatitis is lacking. Effectiveness, safety, patient characteristics, and treatment aspects were investigated in patients taking dupilumab for up to 84 weeks.
Learn more at the Journal of the American Academy of Dermatology.